IL17A and ovarian cancer: In ovarian cancer, γδ T cells and their Vδ1 subset produced IL-17A, impaired antitumor responses, and enhanced immunosuppressive activities, as documented by their ability to inhibit the proliferation of naive CD4+ T cells upon co-culture with ovarian cancer tissue supernatants (49).